参考文献/References:
[1] 嗜铬细胞瘤和副神经节瘤诊断治疗专家共识(2020 版)[J].中华内分泌代谢杂志,2020,36(9):737-750.
[2] Hamidi O,Young W F Jr,Gruber L, et al.Outcomes of patients with metastatic phaeochromocytoma and paraganglioma: a systematic review and meta-analysis[J].Clin Endocrinol(Oxf),2017,87: 440-450.
[3] Lam A K.Update on adrenal tumors in 2017 World Health Organization(WHO)of endocrine tumors[J].Endoer Pathol,2017,28(3):213-227.
[4] 邓建华,李汉忠.转移性嗜铬细胞瘤/副神经节瘤的临床诊断和预后[J].协和医学杂志,2019,10(6):654-659.
[5] Kimura N,Takayanagi R,Takizawa N,et al. Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma[J]. Endocr Relat Cancer,2014,21: 405-414.
[6] 林洁,郭慈仁,陈雪燕, 等.P16蛋白和Ki-67抗原在宫颈上皮内瘤变分级诊断中的价值[J].福建医药杂志,2021,43(6):16-17.
[7] Azizan N, Hayati F, Tizen N M S,et al.Role of coexpression of estrogen receptor beta and Ki-67 in prostate adenocarcinoma[J].Investig Clin Urol, 2018,59(4):232-237.
[8] Domínguez N,Estévez-Herrera J,Pardo M R,et al.The functional role of chromogranin in exocytosis[J].J Mol Neurosci,2012,48(2):317-322.